TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search

CZMWY

Carl Zeiss Meditec AG ADR

PINKCommon Stock
$31.66
+3.87%today

No SEC filings for this security

Carl Zeiss Meditec AG ADR is a foreign or OTC-listed security (PINK) that doesn't file with the SEC, so the grounded research view — financials, filings, insider activity and the call — isn't available. Price and news only.

Key stats

52-week range$26.41 – $60.47
26.4152-week60.47
Market cap
$2.77B
Volume
507.00
1Y return
-51.48%
Beta
1.33

Price · 1Y

$31.66▼ -51.48%
over 1Y
L $26.40H $65.36

Recent news

market news →
ZEISS Meditec Selects Atlas® System from Nirrin Technologies to Modernize Hyaluronic Acid Manufacturing WorkflowsBullish
finance.yahoo.com· 2026-06-30
ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testingBullish
finance.yahoo.com· 2026-06-18
ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testingBullish
finance.yahoo.com· 2026-06-18
ZEISS Medical Technology and Aier Eye Hospital Group Sign Strategic Agreement for 25 VISUMAX 800 UnitsBullish
finance.yahoo.com· 2026-06-17
ZEISS Medical Technology and Aier Eye Hospital Group Sign Strategic Agreement for 25 VISUMAX 800 UnitsBullish
finance.yahoo.com· 2026-06-17
ZEISS announces successful early implantations of the AT LUCIA toric 721P intraocular lensBullish
finance.yahoo.com· 2026-06-11
Earnings Miss: Carl Zeiss Meditec AG Missed EPS And Analysts Are Revising Their ForecastsBullish
finance.yahoo.com· 2026-05-15
ZEISS expands ophthalmic surgical workflows in Mexico with COFEPRIS approval for ARTEVO 850 and MICOR 700Bullish
finance.yahoo.com· 2026-05-13

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.